liferation and neogenesis from precursorcells (16–18). Data obtained in animalmodels also indicate that AC2993 reducesfood intake, causes weight loss, and hasan insulin-sensitizing effect (9,19,20).The present study was undertaken toevaluate the effectiveness of AC2993 inimproving glycemic control among pa-tients with type 2 diabetes who are treatedwith sulfonylureas or metformin, alone orin combination, over a 28-day period. ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●● From Amylin Pharmaceuticals, Inc., San Diego, California. Address correspondence and reprint requests to Alain D. Baron, MD, Amylin Pharmaceuticals, Inc., 9373 Towne Centre Dr., San Diego, CA 92121. E-mail: abaron@amylin.com. Received for publication 27 November 2002 and accepted in revised form 2 May 2003.All of the authors hold stock in Amylin Pharmaceuticals.Abbreviations: AUC, area under the concentration–time curve; BID, twice daily; DPP-IV, dipeptidyl